Cboe BZX · XSHQ
Invesco S&P SmallCap Quality ETF financials
$45.22−0.81%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '22 Jun 30 | Q1 '22 Mar 31 | Q4 '21 Dec 31 | Q3 '21 Sep 30 | Q2 '21 Jun 30 | Q1 '21 Mar 31 | Q4 '20 Dec 31 | Q3 '20 Sep 30 | Q2 '20 Jun 30 | Q1 '20 Mar 31 | Q4 '19 Dec 31 | Q3 '19 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.53B | $1.63B | $1.76B | $1.75B | $1.72B | $1.66B | $1.63B | $1.50B | $1.42B | $1.60B | $1.74B | $1.72B |
| Gross profit | $1.53B | $1.63B | $1.76B | $1.75B | $1.72B | $1.66B | $1.63B | $1.50B | $1.42B | $1.60B | $1.74B | $1.72B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $344.7M | $377.7M | $509.2M | $463.8M | $470.9M | $344.3M | $217.8M | $268.5M | $173.6M | $376.6M | $451.1M | $460.6M |
| Net income | $121.0M | $197.7M | $426.8M | $330.1M | $368.3M | $267.8M | $211.1M | $191.7M | $40.5M | $81.5M | $179.8M | $167.1M |
| Net margin | 7.9% | 12.1% | 24.2% | 18.9% | 21.4% | 16.1% | 13.0% | 12.8% | 2.9% | 5.1% | 10.3% | 9.7% |
| Diluted EPS | $0.26 | $0.43 | $0.91 | $0.71 | $0.79 | $0.58 | $0.45 | $0.41 | $0.09 | $0.18 | $0.39 | $0.36 |
| EBITDA | $394.2M | $462.4M | $456.6M | $502.8M | $476.6M | $441.2M | $377.2M | $375.4M | $223.9M | $425.0M | $451.1M | $509.1M |
| Operating cash flow | $318.3M | -$245.7M | $247.5M | $521.7M | $576.8M | $59.9M | $481.7M | $422.9M | $273.8M | -$163.0M | $413.8M | $390.5M |
| Free cash flow | $285.1M | -$269.6M | $211.9M | $495.7M | $549.9M | $39.6M | $440.3M | $396.3M | $246.0M | -$182.2M | $365.1M | $363.9M |
| Diluted shares | 459.5M | 462.4M | 464.7M | 466.0M | 466.2M | 464.7M | 462.5M | 463.5M | 463.1M | 458.9M | 440.5M | 466.9M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.13B | $1.61B | $2.15B | $2.31B | $1.74B | $1.59B |
| Short-term investments | $9.60B | $10.01B | $9.97B | $9.83B | $9.27B | $8.77B |
| Total debt | $8.40B | $9.17B | $9.42B | $9.55B | $9.12B | $9.13B |
| Total assets | $30.19B | $31.85B | $32.69B | $32.81B | $33.25B | $34.88B |
| Total liabilities | $13.50B | $15.07B | $16.01B | $16.54B | $17.46B | $19.51B |
| Shareholders' equity | $15.79B | $15.99B | $16.17B | $15.73B | $15.43B | $15.03B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology